Literature DB >> 11820771

Modulation of THP-1 macrophage and cholesterol-loaded foam cell apolipoprotein E levels by glycosphingolipids.

Brett Garner1, Howard R Mellor, Terry D Butters, Raymond A Dwek, Frances M Platt.   

Abstract

Macrophages synthesize and secrete apolipoprotein E (apoE) constitutively. This process is upregulated under conditions of cholesterol loading. The response to cholesterol is antiatherogenic as it is believed to promote cholesterol efflux from the artery wall. The concentration of lactosyl ceramide (LacCer), a glycosphingolipid recently discovered to regulate cellular signaling, proliferation, and expression of adhesion molecules, is also increased in atherosclerotic tissues. Here we have investigated the effect of exogenous LacCer on macrophage apoE levels. We show that increasing macrophage LacCer levels sevenfold led to reductions in cellular and secreted apoE (15 and 30%, respectively, over a 24-h period) as determined by enzyme-linked immunosorbent assay. A similar effect was also induced by glucosyl ceramide (GlcCer) but not by ganglioside species. When macrophages were converted to cholesterol-loaded foam cells by incubation with acetylated LDL, the resulting increase in cellular apoE levels was inhibited by 26% when the cells were subsequently enriched with LacCer. After metabolic labeling of cellular glycosphingolipids with [14C]palmitate, we also discovered that high-density lipoprotein (HDL) stimulates the efflux of glycosphingolipids from foam cells. These data imply that LacCer and GlcCer may be proatherogenic due to the suppression of macrophage apoE production. Furthermore, the efflux of glycosphingolipids from macrophage foam cells to HDL could indicate a potential pathway for their removal from the artery wall and subsequent delivery to the liver. ©2002 Elsevier Science (USA).

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11820771     DOI: 10.1006/bbrc.2002.6356

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  9 in total

1.  Plasma concentrations of molecular lipid species predict long-term clinical outcome in coronary artery disease patients.

Authors:  Sharda Anroedh; Mika Hilvo; K Martijn Akkerhuis; Dimple Kauhanen; Kaisa Koistinen; Rohit Oemrawsingh; Patrick Serruys; Robert-Jan van Geuns; Eric Boersma; Reijo Laaksonen; Isabella Kardys
Journal:  J Lipid Res       Date:  2018-06-01       Impact factor: 5.922

2.  Heterogeneous expression of apolipoprotein-E by human macrophages.

Authors:  Nicodemus Tedla; Elias N Glaros; Ulf T Brunk; Wendy Jessup; Brett Garner
Journal:  Immunology       Date:  2004-11       Impact factor: 7.397

3.  Caseation of human tuberculosis granulomas correlates with elevated host lipid metabolism.

Authors:  Mi-Jeong Kim; Helen C Wainwright; Michael Locketz; Linda-Gail Bekker; Gabriele B Walther; Corneli Dittrich; Annalie Visser; Wei Wang; Fong-Fu Hsu; Ursula Wiehart; Liana Tsenova; Gilla Kaplan; David G Russell
Journal:  EMBO Mol Med       Date:  2010-07       Impact factor: 12.137

Review 4.  Metabolic host responses to infection by intracellular bacterial pathogens.

Authors:  Wolfgang Eisenreich; Jürgen Heesemann; Thomas Rudel; Werner Goebel
Journal:  Front Cell Infect Microbiol       Date:  2013-07-09       Impact factor: 5.293

Review 5.  Potential therapeutic targets for atherosclerosis in sphingolipid metabolism.

Authors:  Zemou Yu; Qing Peng; Yining Huang
Journal:  Clin Sci (Lond)       Date:  2019-03-19       Impact factor: 6.124

6.  A disturbed balance between blood complement protective factors (FH, ApoE) and common pathway effectors (C5a, TCC) in acute COVID-19 and during convalesce.

Authors:  Krzysztof Laudanski; Tony Okeke; Kumal Siddiq; Jihane Hajj; Mariana Restrepo; Damodar Gullipalli; Wen-Chao Song
Journal:  Sci Rep       Date:  2022-08-11       Impact factor: 4.996

7.  Myriocin-mediated up-regulation of hepatocyte apoA-I synthesis is associated with ERK inhibition.

Authors:  Elias N Glaros; Woojin S Kim; Brett Garner
Journal:  Clin Sci (Lond)       Date:  2010-03-30       Impact factor: 6.124

8.  Molecular lipids identify cardiovascular risk and are efficiently lowered by simvastatin and PCSK9 deficiency.

Authors:  Kirill Tarasov; Kim Ekroos; Matti Suoniemi; Dimple Kauhanen; Tuulia Sylvänne; Reini Hurme; Ioanna Gouni-Berthold; Heiner K Berthold; Marcus E Kleber; Reijo Laaksonen; Winfried März
Journal:  J Clin Endocrinol Metab       Date:  2013-12-20       Impact factor: 5.958

Review 9.  Sphingolipids in High Fat Diet and Obesity-Related Diseases.

Authors:  Songhwa Choi; Ashley J Snider
Journal:  Mediators Inflamm       Date:  2015-11-16       Impact factor: 4.711

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.